News

Aquestive Therapeutics Announces FDA Acceptance Of New Drug Application And PDUFA Date For Anaphylmtm For The Treatment Of Severe Allergic Reactions
FDA assigns PDUFA target action date of January 31, 2026 WARREN, N.J., June 16, 2025 (GLOBE NEWSWIRE) -- Aquestive Thera ...